Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
1.690
+0.040 (2.42%)
At close: Jul 10, 2026, 4:00 PM EDT
1.660
-0.030 (-1.78%)
After-hours: Jul 10, 2026, 6:23 PM EDT
Biomerica Revenue
Biomerica had revenue of $987.00K in the quarter ending February 28, 2026, a decrease of -11.80%. This brings the company's revenue in the last twelve months to $4.33M, down -23.81% year-over-year. In the fiscal year ending May 31, 2025, Biomerica had annual revenue of $5.31M, down -1.92%.
Revenue (ttm)
$4.33M
Revenue Growth
-23.81%
P/S Ratio
1.21
Revenue / Employee
$80,130
Employees
54
Market Cap
5.22M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 5.31M | -104.00K | -1.92% |
| May 31, 2024 | 5.42M | 76.00K | 1.42% |
| May 31, 2023 | 5.34M | -13.53M | -71.71% |
| May 31, 2022 | 18.87M | 11.67M | 162.13% |
| May 31, 2021 | 7.20M | 506.32K | 7.57% |
| May 31, 2020 | 6.69M | 1.49M | 28.69% |
| May 31, 2019 | 5.20M | -363.51K | -6.53% |
| May 31, 2018 | 5.56M | -227.48K | -3.93% |
| May 31, 2017 | 5.79M | 651.85K | 12.68% |
| May 31, 2016 | 5.14M | 177.45K | 3.58% |
| May 31, 2015 | 4.96M | -158.08K | -3.09% |
| May 31, 2014 | 5.12M | -1.35M | -20.89% |
| May 31, 2013 | 6.47M | 391.83K | 6.44% |
| May 31, 2012 | 6.08M | 1.18M | 24.12% |
| May 31, 2011 | 4.90M | -175.84K | -3.46% |
| May 31, 2010 | 5.08M | 140.45K | 2.85% |
| May 31, 2009 | 4.93M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| Vivos Therapeutics | 19.57M |
| Beyond Air | 7.68M |
| Tenon Medical | 4.60M |
| Intelligent Bio Solutions | 3.91M |
| Catheter Precision | 1.11M |
| Sintx Technologies | 1.03M |
| Nexalin Technology | 275.58K |
BMRA News
- 6 weeks ago - Biomerica enters master services agreement with life sciences company - TheFly
- 6 weeks ago - Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development - GlobeNewsWire
- 2 months ago - Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 - GlobeNewsWire
- 3 months ago - Biomerica announces MAC confirms inFoods IBS test is eligible for coverage - TheFly
- 3 months ago - Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway - GlobeNewsWire
- 3 months ago - Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - GlobeNewsWire
- 3 months ago - Biomerica Reports Third Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 4 months ago - Biomerica receives first commercial order for Hp Detect - TheFly